Silvia Lorenzotti
Overview
Explore the profile of Silvia Lorenzotti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
580
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenzi A, Saccani B, Di Gregorio M, Rossini F, Sollima A, Mule A, et al.
Antibiotics (Basel)
. 2024 Jul;
13(7).
PMID: 39061349
Central nervous system infections are among the most severe infectious conditions in the neonatal period and are still burdened by significant mortality, especially in preterm infants and those with a...
2.
Sollima A, Rossini F, Lanza P, Pallotto C, Meschiari M, Gentile I, et al.
Antibiotics (Basel)
. 2024 May;
13(5).
PMID: 38786181
Cefiderocol is a new molecule effective against multidrug-resistant (MDR) Gram-negative pathogens. Currently, there is limited evidence regarding the use of cefiderocol in central nervous system (CNS) infections. Data on the...
3.
Fumarola B, Signorini L, Lorenzotti S, Lanza P, Saccani B, Van Hauwermeiren E, et al.
Infection
. 2024 Mar;
52(4):1459-1468.
PMID: 38530518
Purpose: COVID-19 associated pulmonary aspergillosis (CAPA) is common and linked with high fatality rates. To assess the impact on the incidence and outcome of CAPA of an antifungal prophylaxis (AFP)...
4.
Mule A, Rossini F, Sollima A, Lenzi A, Fumarola B, Amadasi S, et al.
Antibiotics (Basel)
. 2023 Jul;
12(7).
PMID: 37508277
spp. endocarditis is a severe and hard-to-treat infection. Immunosuppressed subjects and carriers of prosthetic valves or intracardiac devices are at risk. This article presents the case of an immunocompetent 74-year-old...
5.
Malagola M, Turra A, Signorini L, Corbellini S, Polverelli N, Masina L, et al.
Front Oncol
. 2022 Jul;
12:874117.
PMID: 35785189
Background: Infectious complications are a significant cause of morbidity and mortality in patients undergoing allogeneic haematopoietic stem cell transplantation (Allo-SCT). The BATMO (Best-Antimicrobial-Therapy-TMO) is an innovative program for infection prevention...
6.
Meschiari M, Volpi S, Faltoni M, Dolci G, Orlando G, Franceschini E, et al.
JAC Antimicrob Resist
. 2021 Dec;
3(4):dlab188.
PMID: 34909691
Objectives: To describe our real-life experience with cefiderocol in XDR and difficult-to-treat resistant (DTR-P) infections without any other available treatment options. Methods: We included patients with a proven infection due...
7.
Signorini L, Moioli G, Calza S, Van Hauwermeiren E, Lorenzotti S, Fabro G, et al.
Crit Care Explor
. 2021 Jun;
3(6):e0430.
PMID: 34136819
Design: Retrospective analysis of prospectively collected observational data. Setting: University-affiliated adult ICU. Patients: Ninety-two coronavirus disease 2019 patients admitted to the ICU from February 21, 2020, to May 6, 2020....
8.
Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, et al.
Autoimmun Rev
. 2020 May;
19(7):102568.
PMID: 32376398
A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 consecutive patients admitted to the Spedali Civili...
9.
Postorino M, Quiros-Roldan E, Maggiolo F, Di Giambenedetto S, Ladisa N, Lapadula G, et al.
Open AIDS J
. 2016 Aug;
10:136-43.
PMID: 27563366
Background And Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by...
10.
Torti C, Raffetti E, Donato F, Castelli F, Maggiolo F, Angarano G, et al.
Int J Epidemiol
. 2015 Oct;
46(2):e12.
PMID: 26445966
No abstract available.